journal
Journals Medical Letter on Drugs and Th...

Medical Letter on Drugs and Therapeutics

https://read.qxmd.com/read/36897604/in-brief-off-label-amitriptyline-for-insomnia
#1
JOURNAL ARTICLE
In brief: Off-label amitriptyline for insomnia.
(no author information available yet)
No abstract text is available yet for this article.
36897604
March 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36897603/terlipressin-terlivaz-for-hepatorenal-syndrome
#2
JOURNAL ARTICLE
Terlipressin (Terlivaz) for hepatorenal syndrome.
(no author information available yet)
No abstract text is available yet for this article.
36897603
March 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36897602/a-dexamethasone-ophthalmic-insert-dextenza-for-allergic-conjunctivitis
#3
JOURNAL ARTICLE
A dexamethasone ophthalmic insert (Dextenza) for allergic conjunctivitis.
(no author information available yet)
No abstract text is available yet for this article.
36897602
March 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36897601/drugs-for-overactive-bladder
#4
JOURNAL ARTICLE
Drugs for overactive bladder.
(no author information available yet)
No abstract text is available yet for this article.
36897601
March 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877286/in-brief-a-new-breast-cancer-indication-for-sacituzumab-govitecan-trodelvy
#5
JOURNAL ARTICLE
In brief: A new breast cancer indication for sacituzumab govitecan (Trodelvy).
(no author information available yet)
No abstract text is available yet for this article.
36877286
March 6, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877285/mosunetuzumab-lunsumio-for-follicular-lymphoma
#6
JOURNAL ARTICLE
Mosunetuzumab (Lunsumio) for follicular lymphoma.
(no author information available yet)
No abstract text is available yet for this article.
36877285
March 6, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877284/in-brief-adstiladrin-a-gene-therapy-for-bladder-cancer
#7
JOURNAL ARTICLE
In brief: Adstiladrin - a gene therapy for bladder cancer.
(no author information available yet)
No abstract text is available yet for this article.
36877284
March 6, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877283/elacestrant-orserdu-for-advanced-or-metastatic-breast-cancer
#8
JOURNAL ARTICLE
Elacestrant (Orserdu) for advanced or metastatic breast cancer.
(no author information available yet)
No abstract text is available yet for this article.
36877283
March 6, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877282/ublituximab-briumvi-for-relapsing-multiple-sclerosis
#9
JOURNAL ARTICLE
Ublituximab (Briumvi) for relapsing multiple sclerosis.
(no author information available yet)
No abstract text is available yet for this article.
36877282
March 6, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877281/live-fecal-microbiota-rebyota-for-prevention-of-cdi-recurrence
#10
JOURNAL ARTICLE
Live fecal microbiota (Rebyota) for prevention of CDI recurrence.
(no author information available yet)
No abstract text is available yet for this article.
36877281
March 6, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877280/antiviral-drugs-for-covid-19-in-vaccinated-outpatients
#11
JOURNAL ARTICLE
Antiviral drugs for COVID-19 in vaccinated outpatients.
(no author information available yet)
No abstract text is available yet for this article.
36877280
March 6, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877245/in-brief-a-second-indication-for-tucatinib-tukysa
#12
JOURNAL ARTICLE
In brief: A second indication for tucatinib (Tukysa).
(no author information available yet)
No abstract text is available yet for this article.
36877245
February 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877244/pirtobrutinib-jaypirca-a-fourth-bruton-s-tyrosine-kinase-inhibitor-for-mantle-cell-lymphoma
#13
JOURNAL ARTICLE
Pirtobrutinib (Jaypirca): A fourth Bruton's tyrosine kinase inhibitor for mantle cell lymphoma.
(no author information available yet)
No abstract text is available yet for this article.
36877244
February 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36877243/in-brief-zanubrutinib-brukinsa-for-cll-or-sll
#14
JOURNAL ARTICLE
In brief: Zanubrutinib (Brukinsa) for CLL or SLL.
(no author information available yet)
No abstract text is available yet for this article.
36877243
February 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36757837/in-brief-semaglutide-wegovy-for-weight-loss-in-children
#15
JOURNAL ARTICLE
In brief: Semaglutide (Wegovy) for weight loss in children.
(no author information available yet)
No abstract text is available yet for this article.
36757837
February 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36757836/in-brief-expanded-acess-to-mifepristone
#16
JOURNAL ARTICLE
In brief: Expanded acess to mifepristone.
(no author information available yet)
No abstract text is available yet for this article.
36757836
February 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36757835/deucravacitinib-sotyktu-for-plaque-psoriasis
#17
JOURNAL ARTICLE
Deucravacitinib (Sotyktu) for plaque psoriasis.
(no author information available yet)
No abstract text is available yet for this article.
36757835
February 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36757834/drugs-for-hypothyroidism
#18
JOURNAL ARTICLE
Drugs for hypothyroidism.
(no author information available yet)
No abstract text is available yet for this article.
36757834
February 20, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36757354/tremelimumab-imjudo-for-metastatic-nsclc
#19
JOURNAL ARTICLE
Tremelimumab (Imjudo) for metastatic NSCLC.
(no author information available yet)
No abstract text is available yet for this article.
36757354
February 6, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36757353/table-inhibitors-and-inducers-of-cyp-enzymes-p-glycoprotein-and-other-transporters
#20
JOURNAL ARTICLE
Table: Inhibitors and inducers of CYP enzymes, P-glycoprotein, and other transporters.
(no author information available yet)
No abstract text is available yet for this article.
36757353
February 6, 2023: Medical Letter on Drugs and Therapeutics
next page »
journal
journal
25582
1
2
Make the most of Read.
Download the mobile app.
Fetch more papers »
Fetching more papers... Fetching...

Read by QxMD is copyright © 2023 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

╳

We want to hear from doctors like you!

Take a second to answer a survey question.

╳